Oregon Health and Science University clinical trial pipeline

18 trials changed in the last 30 days: 1 stopped, 9 with notable changes, 8 with minor changes only.

1. Stopped

   COVID-19 VaccinE Response and Co-Administration in Rheumatology…COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)

   Trial terminated

   Oregon Health and Science University·Phase 4· NCT05543642· Registry history of NCT05543642 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

2. Notable

   BM-MNCs for Lower Extremity Compartment Syndrome Injury

   Primary completion pushed from Dec 2025 to Dec 2027

   Also in this update: Study completion pushed from Jun 2026 to Jun 2028

   Oregon Health and Science University·Phase 1· NCT03880656· Registry history of NCT03880656 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

3. Notable

   Cefotetan Therapy for Escherichia Coli Infections

   Primary completion pushed from Feb 2028 to Oct 2028

   Also in this update: Enrollment reduced: 84 → 50 participants; Recruitment opened

   Oregon Health and Science University·Phase 2· NCT07318584· Registry history of NCT07318584 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

4. Notable

   FACT · Food and Circadian Timing

   Primary and study completion pushed from Mar 31, 2026 to Mar 31, 2027

   Oregon Health and Science University·Not applicable· NCT04743271· Registry history of NCT04743271 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

5. Notable

   Tubal Selective Delivery System

   Primary completion pushed from Dec 2027 to Dec 2028

   Also in this update: Study completion pushed from Mar 2028 to Mar 2029

   Oregon Health and Science University·Not applicable· NCT05775913· Registry history of NCT05775913 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

6. Notable

   CaSS · Cannabis Association With Sleep Study

   Recruitment opened

   Oregon Health and Science University·Not applicable· NCT06982950· Registry history of NCT06982950 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

7. Notable

   TRIUMPH · Topical Ruxolitinib · Pyoderma Gangrenosum

   Recruitment opened

   Oregon Health and Science University·Phase 2· NCT07783412· Registry history of NCT07783412 on ClinicalTrials.gov (opens the registry)

   Oct 9, 2026

8. Notable

   Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot…Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study

   Recruitment opened

   Oregon Health and Science University·Phase 1· NCT06988319· Registry history of NCT06988319 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

9. Notable

   Postural Motor Activation Deficits After mTBI; Translating…Postural Motor Activation Deficits After mTBI; Translating Laboratory Findings to Clinical Care

   Recruitment opened

   Oregon Health and Science University·Not applicable· NCT07549529· Registry history of NCT07549529 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

10. Notable

    AF SWCRT-CDS · Optimizing Stroke Prophylaxis of Acute Atrial…AF SWCRT-CDS · Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation With an Electronic Clinical Decision Support Tool

    Primary completion date changed from estimate of Mar 1, 2026 to Aug 30, 2026

    Also in this update: Trial status changed: Enrolling by Invitation → Active, Not Recruiting; Study completion pushed from May 1, 2026 to May 1, 2027

    Oregon Health and Science University·Not applicable· NCT05341986· Registry history of NCT05341986 on ClinicalTrials.gov (opens the registry)

    Oct 16, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.